Curcumin ameliorates cognitive dysfunction and oxidative damage in phenobarbitone and carbamazepine administered rats

European Journal of Pharmacology

Volumn 644, Issue 1-3, 2010, Pages 106-112

  Reeta, K H ^a   Mehla, Jogender ^a   Gupta, Yogendra Kumar ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Carbamazepine; Curcumin; Glutathione; Learning; Lipid peroxidation; Memory; Phenobarbitone

Indexed keywords

CARBAMAZEPINE; CURCUMIN; GLUTATHIONE; MALONALDEHYDE; PHENOBARBITAL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC DRUG ADMINISTRATION; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG POTENTIATION; LEARNING DISORDER; MALE; MAZE TEST; MEMORY DISORDER; MENTAL PERFORMANCE; NONHUMAN; OXIDATIVE STRESS; PASSIVE AVOIDANCE; PRIORITY JOURNAL; RAT;

ANIMALS; ANTICONVULSANTS; ANTIOXIDANTS; AVOIDANCE LEARNING; BRAIN; CARBAMAZEPINE; COGNITION DISORDERS; CURCUMIN; DRUG INTERACTIONS; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; MAZE LEARNING; MEMORY DISORDERS; OXIDATIVE STRESS; PHENOBARBITAL; RATS; RATS, WISTAR;

EID: 77955774680     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.07.022     Document Type: Article

References (54)

1. Adams J., Vorhees C.V., Middaugh L.D. Developmental neurotoxicity of anticonvulsants: human and animal evidence on phenytoin. Neurotoxicol. Teratol. 1940, 12:203-214.
2. Aggarwal B.B., Sung B. Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets. Trends Pharmacol. Sci. 2009, 30:85-94.
3. Aldenkamp A.P., Alpherts W.C., Blennow G., Elmqvist D., Heijbel J., Nilsson H.L., Sandstedt P., Tonnby B., Wåhlander L., Wosse E. Withdrawal of antiepileptic medication in children - effects on cognitive function: the multicentre Holmfrid study. Neurology 1993, 43:41-50.
4. Arora T., Mehta A.K., Sharma K.K., Mediratta P.K., Banerjee B.D., Garg G.R., Sharma A.K. Effect of carbamazepine and lamotrigine on cognitive function and oxidative stress in brain during chemical epileptogenesis in rats. Basic Clin. Pharmacol. Toxicol. 2010, 106:372-377.
5. Aycicek A., Iscan A. The effects of carbamazepine, valproic acid and phenobarbital on the oxidative and antioxidative balance in epileptic children. Eur. Neurol. 2007, 57:65-69.
6. Berr C., Balansard B., Arnaud J. Cognitive decline is associated with systemic oxidative stress: the EVA study, Etude du Viellissement Arteriel. J. Am. Geriatr. Soc. 2000, 48:1285-1291.
7. Blatt S.L., Takahashi R.N. Memory-impairing effects of local anesthetics in an elevated plus-maze test in mice. Braz. J. Med. Biol. Res. 1998, 31:555-559.
8. Da Cunha I.C., José R.F., Orlandi Pereira L., Pimenta J.A., Oliveira de Souza I.A., Reiser R., Moreno H., Marino Neto J., Paschoalini M.A., Faria M.S. The role of nitric oxide in the emotional learning of rats in the plus-maze. Physiol. Behav. 2005, 84:351-358.
9. De Boer T., Stoof J.C., Duijin H. The effect of convulsant and anticonvulsant drugs on the release of radio labeled GABA glutamate noradrenaline, serotonin and acetylcholine from rat cortical slices. Brain Res. 1990, 253:153-160.
10. Diaz J., Schain R.J., Bailey B.G. Phenobarbital-induced brain growth retardation in artificially reared rat pups. Biol. Neonate 1997, 32:77-82.
11. Dodrill C.B. Neuropsychological effects of seizures. Epilepsy Behav. 2004, 5:S21-S24.
12. Elger C.E., Helmstaedter C., Kurthen M. Chronic epilepsy and cognition. Lancet Neurol. 2004, 3:663-672.
13. Ellman G.L. Tissue sulfhydryl groups. Arch. Biochem. Biophys. 1959, 82:70-77.
14. Fisher J.E., Vorhees C. Developmental toxicity of antiepileptic drugs: relationship to postnatal dysfunction. Pharmacol. Res. 1992, 26:207-221.
15. Fukui K., Omoi N.O., Hayasaka T., Shinnkai T., Suzuki S., Abe K., Urano S. Cognitive impairment of rats caused by oxidative stress and aging and its prevention by vitamin E. Ann. NY Acad. Sci. 2002, 959:275-284.
16. Gallagher M., Landfield P.W., McEwen B. Hippocampal neurodegeneration in aging. Science 1996, 274:484-485.
17. Gannaway D.J., Mawer G.E. Serum phenytoin concentration and clinical response in patients with epilepsy. Br. J. Clin. Pharmacol. 1981, 12:833-839.
18. Garcia-Alloza M., Borrelli L.A., Rozkalne A., Hyman B.T., Bacskai B.J. Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model. J. Neurochem. 2007, 102:1095-1104.
19. Herranz J.L. Cognitive repercussion of early-onset epilepsies. Rev. Neurol. 2007, 44:S43-S45.
20. Itoh J., Nabeshima T., Kameyama T. Utility of an elevated plus-maze for the evaluation of memory in mice: effects of nootropics, scopolamine and electroconvulsive shock. Psychopharmacology 1990, 101:27-33. (Berl).
21. Jefremov V., Zilmer M., Zilmer K., Bogdanovic N., Karelson E. Antioxidative effects of plant polyphenols: from protection of G protein signaling to prevention of age-related pathologies. Ann. NY Acad. Sci. 2007, 1095:449-457.
22. Jiang J., Wang W., Sun Y.J., Hu M., Li F., Zhu D.Y. Neuroprotective effect of curcumin on focal cerebral ischemic rats by preventing blood-brain barrier damage. Eur. J. Pharmacol. 2007, 561:54-62.
23. Joshi J., Ghaisas S., Vaidya A., Vaidya R., Kamat D.V., Bhagwat A.N., Bhide S. Early human safety study of turmeric oil (Curcuma longa oil) administered orally in healthy volunteers. J. Assoc. Physicians India 2003, 51:1055-1060.
24. Keller J.N., Schmitt F.A., Scheff S.W., Ding Q., Chen Q., Butterfield D.A., Markesbery W.R. Evidence of increased oxidative damage in subjects with mild cognitive impairment. Neurology 2005, 64:1152-1156.
25. Kleinberger N., Yanai J. Early phenobarbital-induced alterations in hippocampal acetylcholinesterase activity and behavior. Brain Res. 1985, 354:113-123.
26. Lim G.P., Chu T., Yang F., Lim G.P., Beech W., Frautschy S.A., Cole G.M. The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J. Neurosci. 2001, 21:8370-8377.
27. Meador K.J., Loring D.W., Moore E.E., Thompson W.O., Nichols M.E., Oberzan R.E., Durkin M.W., Gallagher B.B., King D.W. Comparative cognitive effects of phenobarbital, phenytoin, and valproate in healthy adults. Neurology 1995, 45:1494-1499.
28. Middaugh L.D., Santos C.A., Zemp J.W. Effects of phenobarbital given to pregnant mice on behavior of mature offspring. Dev. Psychobiol. 1975, 8:305-313.
29. Middaugh L.D., Santos C.A., Zemp J.W. Phenobarbital during pregnancy alters operant behavior of offspring in C57 BL/6J mice. Pharmacol. Biochem. Behav. 1975, 3:1137-1139.
30. Ohkawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal's tissues by thiobarbituric acid reaction. Anal. Biochem. 1979, 95:351-358.
31. Park S.P., Kwon S.H. Cognitive effects of antiepileptic drugs. J. Clin. Neurol. 2008, 4:99-106.
32. Parnas J., Gram L., Flchs H. Psychopharmacological aspects of antiepileptic treatment. Prog. Neurobiol. 1980, 15:19-38.
33. Patsalos P.N., Berry D.J., Bourgeois B.F., Cloyd J.C., Glauser T.A., Johannessen S.I., Leppik I.E., Tomson T., Perucca E. Antiepileptic drugs-best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies. Epilepsia 2008, 49:1239-1276.
34. Perkins A.J., Hendrie H.C., Callahan C.M. Association of antioxidants with memory in a multiethnic elderly sample using the Third National Health and Nutrition Examination survey. Am. J. Epidemiol. 1999, 150:37-44.
35. Perrig W.J., Perrig P., Stahelin H.B. The relation between antioxidants and memory performance in the old and very old. J. Am. Geriatr. Soc. 1997, 45:718-724.
36. Pitkanen A., Sutula T.P. Is epilepsy a progressive disorder? Prospects for new therapeutic approaches in temporal-lobe epilepsy. Lancet Neurol. 2002, 1:173-181.
37. Reeta K.H., Mehla J., Gupta Y.K. Curcumin is protective against phenytoin-induced cognitive impairment and oxidative stress in rats. Brain Res. 2009, 1301:52-60.
38. Rinaldi P., Polidori M.C., Metasstasio A. Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer's disease. Neurobiol. Aging 2003, 24:915-919.
39. Rodriquiz R.M., Wetsel W.C. Assessment of cognitive deficits in mutant mice. Animal Models of Cognitive Impairment 2006, 223-269. Taylor and Francis Group, FL, USA. E.D. Levin, J.J. Buccafusco (Eds.).
40. Serrano F., Klann E. Reactive oxygen species and synaptic plasticity in the aging hippocampus. Ageing Res. Rev. 2004, 3:431-443.
41. Shannon H.E., Love P.L. Effects of antiepileptic drugs on attention as assessed by a five choice strial reaction time task in rats. Epilepsy Behav. 2007, 7:620-628.
42. Sharma A.C., Kulkarni S.K. Evaluation of learning and memory mechanisms employing elevated plus-maze in rats and mice. Prog. Neuropsychopharmacol. Biol. Psychiatry 1992, 16:117-129.
43. Sudha S., Lakshmana M.K., Pradhan N. Phenobarbital in the anticonvulsant dose range does not impair learning and memory or alter brain AChE activity or monoamine levels. Pharmacol. Biochem. Behav. 1996, 54:633-638.
44. Tham C.L., Liew C.Y., Lam K.W., Mohamad A.S., Kim M.K., Cheah Y.K., Zakaria Z.A., Sulaiman M.R., Lajis N.H., Israf D.A. A synthetic curcuminoid derivative inhibits nitric oxide and proinflammatory cytokine synthesis. Eur. J. Pharmacol. 2010, 628:247-254.
45. Thompson P.J., Trimble M.R. Anticonvulsant serum levels relationship to impairments of cognitive functioning. J. Neurol. Neurosurg. Psychiatry 1983, 46:227-233.
46. Tonekaboni S.H., Beyraghi N., Tahbaz H.S., Bahreynian S.A., Aghamohammadpoor M. Neurocognitive effects of phenobarbital discontinuation in epileptic children. Epilepsy Behav. 2006, 8:145-148.
47. Trimble M.R., Robertson M.M., Coppen A. The dexamethasone suppression test in medicated epileptic patients. Biol. Psychiatry 1986, 21:225-238.
48. 2 receptors. Eur. J. Pharmacol. 2008, 578:43-50.
49. Warner A., Privitera M., Bates D. Standards of laboratory practice: antiepileptic drug monitoring. National Academy of Clinical Biochemistry. Clin. Chem. 1998, 44:1085-1095.
50. Wesnes K.A., Edgar C., Dean A.D., Wroe S.J. The cognitive and psychomotor effects of remacemide and carbamazepine in newly diagnosed epilepsy. Epilepsy Behav. 2009, 14:522-528.
51. Yanai J., Fares F., Gavish M., Greenfeld Z., Katz Y., Marcovici G., Pick C.G., Rogel-Fuchs Y., Weizman A. Neural and behavioral alterations after early exposure to phenobarbital. Neurotoxicology 1989, 10:543-554.
52. Yanai J., Rosselli-Austin L., Tabakoff B. Neuronal deficits in mice following prenatal exposure to phenobarbital. Exp. Neurol. 1979, 64:237-244.
53. Yang F., Lim G.P., Begum A.N., Ubeda O.J., Simmons M.R., Ambegaokar S.S., Chen P.P., Kayed R., Glabe C.G., Frautschy S.A., Cole G.M. Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in-vivo. J. Biol. Chem. 2005, 280:5892-5901.
54. Zhao J., Zhao Y., Zheng W., Lu Y., Feng G., Yu S. Neuroprotective effect of curcumin on transient focal cerebral ischemia in rats. Brain Res. 2008, 1229:224-232.